Categories: Research

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

UCSF School of Pharmacy’s 32nd year of top NIH funding includes many new projects

For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

New NIH funding awarded to the Department of Pharmaceutical Chemistry in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Pharmaceutical Chemistry:

Desai receives Dawson Biotechnology Award

UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.

Artificial kidney project led by Roy chosen for accelerated FDA program

The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).

New NIH funding awarded to UCSF School of Pharmacy postdoctoral fellows in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included two on-going projects by postdoctoral fellows:

Shoichet is the new director of the QB3 at UCSF

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences (QB3) at UCSF.

The HIV pharmacist: helping patients pick and stick with lifesaving drugs

How do you convince patients who feel fine to take medicines that can have major side effects?

How can you help them stay on their lifesaving daily medications for years to come despite the obstacle course of everyday life?

Study finds including unpublished FDA data alters drug effectiveness outcomes

Every year U.S. drug regulators approve dozens of new medicines as “safe and effective,” but just how effective are they? How well do they alleviate specific aspects of illness, whether light sensitivity from migraine headaches or itching from eczema?

Partners in D program wins AACP Award for Student Community Service

Partners in D, the innovative program in which UCSF student pharmacists help both underserved seniors and fellow health professionals maximize the complex Medicare Part D drug benefit, has won a national award for community service.

Pages